SiHa Cells
















General information
Description | SiHa cells are a human cervical squamous cell carcinoma cell line that has been widely used in research for several decades. They were isolated from primary uterine biopsy fragments from a 55-year-old female Japanese patient with squamous cell carcinoma. This cell line is of great interest to researchers studying cervical cancer and other related diseases due to their unique genetic characteristics. SiHa cells have been found to express the p53+ and pRB+ genes, which are involved in cell cycle regulation, DNA repair, and tumor suppression. These genes make SiHa cells an ideal model for studying the molecular mechanisms of cancer development and progression. Additionally, SiHa cells are a suitable transfection host, making them an excellent tool for gene expression studies. SiHa cells have a hypertriploid karyotype, with an average chromosome number between 69 and 72. The SiHa cells are HPV-16 positive, showing integration of 1 to 2 copies of the viral genome per cell. Cells are tumorigenic, forming poorly differentiated epidermoid carcinoma (grade III) in nude mice. This makes them an excellent model for studying cancer progression and testing anti-cancer drugs. SiHa cell line expresses various isoenzymes, including AK-1, ES-D, G6PD, GLO-I, Me-2, PGM1, and PGM3. Electron microscopy revealed abundant tonofilaments in the cytoplasm and desmosomes at the cell junctions. The growth properties of SiHa cells are adherent, with a doubling time of 17 hours in 10% FBS media and 21 hours in 5% FBS media. Epithelial cell adhesion molecule (EpCAM) expression is present in 92% of SiHa cells, indicating their epithelial origin. They show strong cytokeratin expression but no vimentin expression. |
---|---|
Organism | Human |
Tissue | Cervix |
Disease | Human papillomavirus-related cervical squamous cell carcinoma |
Synonyms | Siha, SIHA |
Characteristics
Age | 55 years |
---|---|
Gender | Female |
Ethnicity | Asian |
Morphology | Epithelial |
Growth properties | Adherent |
Identifiers / Biosafety / Citation
Citation | SiHa (Cytion catalog number 305023) |
---|---|
Biosafety level | 1 |
Expression / Mutation
Tumorigenic | Yes |
---|
Handling
Culture Medium | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
---|---|
Medium supplements | Supplement the medium with 10% FBS and 1% NEAA |
Passaging solution | Accutase |
Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
Split ratio | 1:2 to 1:4 |
Fluid renewal | 2 to 3 times per week |
Freeze medium | As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
Handling of cryopreserved cultures |
|
Quality control / Genetic profile / HLA
Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
---|---|
STR profile |
Amelogenin: x,x
CSF1PO: 12
D13S317: 11
D16S539: 12
D5S818: 9
D7S820: 10
TH01: 6,9
TPOX: 8
vWA: 14,17
D3S1358: 16,17
D21S11: 31
D18S51: 15
Penta E: 10,12
Penta D: 9
D8S1179: 13,16
FGA: 21
D6S1043: 18
D2S1338: 24
D12S391: 19,22
D19S433: 14. Feb
|
Certificate of Analysis (CoA)
Lot Number | Certificate Type | Date | Catalog Number |
---|---|---|---|
305023-160124 | Certificate of Analysis | 23. May. 2025 | 305023 |